- Home
- PVLA vs RM Comparison
PVLA vs RM Comparison
Compare PVLA & RM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PVLA
- RM
- Stock Information
- Founded
- PVLA 2015
- RM 1987
- Country
- PVLA United States
- RM United States
- Employees
- PVLA N/A
- RM N/A
- Industry
- PVLA Biotechnology: Pharmaceutical Preparations
- RM Finance: Consumer Services
- Sector
- PVLA Health Care
- RM Finance
- Exchange
- PVLA Nasdaq
- RM Nasdaq
- Market Cap
- PVLA 280.4M
- RM 298.3M
- IPO Year
- PVLA N/A
- RM 2012
- Fundamental
- Price
- PVLA $22.77
- RM $28.89
- Analyst Decision
- PVLA Strong Buy
- RM Hold
- Analyst Count
- PVLA 7
- RM 3
- Target Price
- PVLA $44.43
- RM $30.00
- AVG Volume (30 Days)
- PVLA 82.1K
- RM 47.5K
- Earning Date
- PVLA 05-15-2025
- RM 04-30-2025
- Dividend Yield
- PVLA N/A
- RM 4.15%
- EPS Growth
- PVLA N/A
- RM 41.13
- EPS
- PVLA N/A
- RM 3.29
- Revenue
- PVLA N/A
- RM $577,647,000.00
- Revenue This Year
- PVLA N/A
- RM $14.45
- Revenue Next Year
- PVLA N/A
- RM $8.95
- P/E Ratio
- PVLA N/A
- RM $8.77
- Revenue Growth
- PVLA N/A
- RM 6.45
- 52 Week Low
- PVLA $6.20
- RM $25.41
- 52 Week High
- PVLA $29.27
- RM $37.52
- Technical
- Relative Strength Index (RSI)
- PVLA N/A
- RM 41.75
- Support Level
- PVLA N/A
- RM $26.18
- Resistance Level
- PVLA N/A
- RM $29.48
- Average True Range (ATR)
- PVLA 0.00
- RM 1.46
- MACD
- PVLA 0.00
- RM -0.35
- Stochastic Oscillator
- PVLA 0.00
- RM 34.28
About PVLA Palvella Therapeutics Inc. Common Stock
Palvella Therapeutics Inc is a late clinical-stage biopharmaceutical company committed to serving individuals suffering from serious, rare genetic skin diseases without approved therapies. The Company's lead product candidate, QTORIN 3.9 percent rapamycin anhydrous gel (QTORIN rapamycin), is based on the Company's patented QTORIN platform. QTORIN rapamycin is in clinical development for two rare genetic skin disorders.
About RM Regional Management Corp.
Regional Management Corp is a diversified consumer finance company that provides installment loan products to customers with limited access to consumer credit from banks, thrifts, credit card companies, and other lenders. It is engaged in consumer finance. The company has the core products which are small and large installment loans. The company also offers optional payment and collateral protection insurance. The company's principal source of revenue is interest and fee income on outstanding loans.